8-K

COHEN & STEERS, INC. (CNS)

8-K 2024-12-17 For: 2024-12-12
View Original
Added on April 07, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________________

FORM 8-K

_____________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): December 12, 2024

_____________________

Cohen & Steers, Inc.

(Exact Name of Registrant as Specified in Charter)

_____________________

Delaware 001-32236 14-1904657
(State or Other Jurisdiction<br>of Incorporation) (Commission File Number) (IRS Employer<br>Identification No.)

1166 Avenue of the Americas

New York, NY 10036

(Address of principal executive offices and Zip Code)

(212) 832-3232

(Registrant's telephone number, including area code)

_________________________________________<br><br>(Former name or former address, if changed since last report)

________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.01 par value CNS New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 17, 2024, Cohen & Steers, Inc. (the “Company”) issued a press release announcing the appointment of Jon Cheigh, Executive Vice President and Chief Investment Officer, as the Company’s President, effective January 1, 2025. Mr. Cheigh succeeds Joseph Harvey, the Company’s Chief Executive Officer and a member of its Board of Directors. Mr. Harvey served as the Company’s President since 2003 and will continue to serve as its Chief Executive Officer and a member of its Board of Directors.

Item 7.01 Regulation FD Disclosure.

A copy of the press release announcing the appointment of Mr. Cheigh as the Company’s President is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The exhibits listed on the exhibit index accompanying this Current Report on Form 8-K are furnished herewith.

Exhibit No. Description
99.1 Press release dated December 17, 2024
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Cohen & Steers, Inc.<br><br>(Registrant)
Date: December 17, 2024 By: /s/ Francis C. Poli
--- --- ---
Name: Francis C. Poli<br><br>Title: Executive Vice President, General Counsel and Secretary

Document

Exhibit 99.1

Cohen & Steers, Inc.

1166 Avenue of the Americas

New York, NY 10036

212 832 3232

cnslogo21.jpg

Contact:

Robert Klemens

Vice President

Communications

212 796 9377

Cohen & Steers Appoints Jon Cheigh as President

NEW YORK, December 17, 2024—Cohen & Steers, Inc. (NYSE: CNS) has appointed Jon Cheigh as President, effective January 1, 2025. Mr. Cheigh remains Chief Investment Officer and will continue to focus the majority of his time on leading the investment department. The appointment reflects Mr. Cheigh's success as a leader and mentor, and is part of the firm’s long-term planning for leadership by investment professionals.

Mr. Cheigh joined Cohen & Steers in 2005 as a research analyst on the U.S. Real Estate team. He was promoted to portfolio manager in 2008, was made Head of Global Real Estate in 2012 and Chief Investment Officer in 2019.

Joseph Harvey, Chief Executive Officer, said:

"We were fortunate to recruit Jon 20 years ago. Over the years, Jon has played a transformative role in our real estate team and investment department, having consistently delivered alpha and instituted a culture of creativity, innovation, teamwork and excellence. Jon’s appointment as President not only acknowledges his significant impact but also sets the stage for the next generation of leadership to ensure the continued success and growth of our firm."

Jon Cheigh, Chief Investment Officer, said:

"While I will continue to focus on coaching investment teams and elevating our industry leading investment performance, I look forward to working with Joe and the Executive Committee to drive the strategic growth of the firm. I would like to thank Joe, Bob Steers and Marty Cohen for their many years of mentorship.”

About Cohen & Steers. Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, Tokyo and Singapore.

SOURCE: Cohen & Steers

CONTACT: Robert Klemens

Vice President, Communications, Cohen & Steers

media@cohenandsteers.com

Website: https://www.cohenandsteers.com

Symbol: NYSE: CNS

1